Search results for: 'push growth changes'

The medical device industry faces significant pricing pressures as the consumables and services segment gains traction from activities tied to installing new equipment and replacing or refurbishing capital equipment. Medical device vendors are focused on new business models to provide multi-vendor services, online parts ordering, remote servicing, ...

The global healthcare industry is in the midst of a major transformation, a process that was accelerated by the COVID-19 pandemic. Several mega trends and disruptive technologies have converged to drive this transformation across the healthcare ecosystem. In this study, Frost & Sullivan builds upon previous analysis on the future of healthcare for ...

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interventional and image-guided therapy; physiology and f...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers. This analysis e...

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

The healthcare industry is undergoing a massive transformation, with a high focus on personalization and patient-centric care. It is embracing digital transformation and becoming more consumer-/patient friendly. The changing socioeconomic landscape, the high prevalence of chronic diseases, the massive COVID-19 pandemic, and the challenge of resourc...

The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.The report sheds light on technology innovations ...